WLKP · Westlake Chemical Partners LP - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $305.68M | - | $308.90M | $297.12M | $237.63M | - | $277.00M | $284.17M | $284.67M | - |
| Cost of Revenue | $211.92M | - | $209.47M | $199.59M | $183.55M | - | $160.05M | $182.94M | $182.49M | - |
| Gross Profit | $93.76M | - | $99.42M | $97.53M | $54.08M | - | $116.94M | $101.23M | $102.18M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $7.19M | - | $7.44M | $6.30M | $7.47M | - | $7.25M | $7.61M | $7.08M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $34.30M | - | $21.97M | $21.59M | $27.07M | - | $21.63M | $21.83M | $27.99M | - |
| Operating Income | $86.57M | - | $91.98M | $91.23M | $46.61M | - | $109.69M | $93.63M | $95.10M | - |
| Interest Expense | $5.08M | - | $6.70M | $6.65M | $6.58M | - | - | - | - | - |
| Income Tax | $177.0K | - | $42.0K | $205.0K | $107.0K | - | $216.0K | $207.0K | $210.0K | - |
| Net Income | $14.17M | - | $14.65M | $14.56M | $4.95M | - | $18.14M | $14.43M | $14.83M | - |
| EPS - Basic | - | - | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44.29M | $44.27M | $37.94M | $36.58M | $49.62M | $58.32M | $60.21M | $66.00M | $55.76M | $58.62M |
| Accounts Receivable | $19.78M | $9.11M | $16.14M | $12.82M | $13.01M | $11.58M | $22.51M | $27.13M | $27.23M | $18.70M |
| Inventory | $3.09M | $2.77M | $3.08M | $3.26M | $2.73M | $4.06M | $3.75M | $4.49M | $4.86M | $4.43M |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $148.90M | $143.51M | $130.86M | $156.52M | $225.15M | $240.93M | $241.56M | $232.13M | $224.35M | $226.20M |
| Total Assets | $1.24B | $1.26B | $1.27B | $1.31B | $1.37B | $1.29B | $1.29B | $1.29B | $1.30B | $1.32B |
| Current Liabilities | $40.79M | $51.30M | $55.13M | $72.91M | $164.82M | $55.37M | $53.29M | $49.61M | $43.08M | $56.34M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $443.31M | $454.18M | $458.30M | $476.02M | $568.25M | $458.64M | $456.88M | $453.51M | $446.83M | $460.59M |
| Stockholders' Equity | - | - | - | - | - | - | - | - | - | - |
| Retained Earnings | - | - | - | - | - | - | - | - | - | - |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $110.20M | - | - | - | $45.78M | - | - | - | $104.56M | - |
| Investing Cash Flow | ($18.56M) | - | - | - | $14.04M | - | - | - | ($9.77M) | - |
| Financing Cash Flow | ($91.62M) | - | - | - | ($68.52M) | - | - | - | ($97.65M) | - |
| CapEx | $5.56M | - | - | - | $15.96M | - | - | - | $9.77M | - |
| Free Cash Flow | $104.64M | - | - | - | $29.82M | - | - | - | $94.79M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 30.7% | - | 32.2% | 32.8% | 22.8% | - | 42.2% | 35.6% | 35.9% | - |
| Operating margin | 28.3% | - | 29.8% | 30.7% | 19.6% | - | 39.6% | 32.9% | 33.4% | - |
| EBITDA margin | 39.5% | - | 36.9% | 38.0% | 31.0% | - | 47.4% | 40.6% | 43.2% | - |
| Net margin | 4.6% | - | 4.7% | 4.9% | 2.1% | - | 6.5% | 5.1% | 5.2% | - |
| Free cash flow margin | 34.2% | - | - | - | 12.6% | - | - | - | 33.3% | - |
| FCF / Net income | 7.39 | - | - | - | 6.03 | - | - | - | 6.39 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 2.4% | - | 2.4% | 2.1% | 3.1% | - | 2.6% | 2.7% | 2.5% | - |
| Effective tax rate | 1.2% | - | 0.3% | 1.4% | 2.1% | - | 1.2% | 1.4% | 1.4% | - |
| Return on assets | 1.1% | - | 1.2% | 1.1% | 0.4% | - | 1.4% | 1.1% | 1.1% | - |
| Return on equity | - | - | - | - | - | - | - | - | - | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 3.65 | 2.80 | 2.37 | 2.15 | 1.37 | 4.35 | 4.53 | 4.68 | 5.21 | 4.02 |
| Quick ratio | 3.57 | 2.74 | 2.32 | 2.10 | 1.35 | 4.28 | 4.46 | 4.59 | 5.09 | 3.94 |
| Cash ratio | 1.09 | 0.86 | 0.69 | 0.50 | 0.30 | 1.05 | 1.13 | 1.33 | 1.29 | 1.04 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 17.0x | - | 13.7x | 13.7x | 7.1x | - | - | - | - | - |
| Equity multiplier | - | - | - | - | - | - | - | - | - | - |
| Liabilities / Assets | 0.36 | 0.36 | 0.36 | 0.36 | 0.41 | 0.36 | 0.35 | 0.35 | 0.35 | 0.35 |
| Efficiency | ||||||||||
| Asset turnover | 0.25 | - | 0.24 | 0.23 | 0.17 | - | 0.21 | 0.22 | 0.22 | - |
| Inventory turnover | 68.51 | - | 68.06 | 61.20 | 67.16 | - | 42.67 | 40.77 | 37.55 | - |
| Days sales outstanding | 24d | - | 19d | 16d | 20d | - | 30d | 35d | 35d | - |
| Days inventory outstanding | 5d | - | 5d | 6d | 5d | - | 9d | 9d | 10d | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 28.6% | - | 11.5% | 4.6% | -16.5% | - | -13.9% | 7.6% | -7.5% | - |
| Revenue CAGR (3y) | -0.2% | - | -9.4% | -12.8% | -13.1% | - | -2.0% | -4.1% | 2.0% | - |
| Revenue CAGR (5y) | 2.6% | - | 5.9% | 4.5% | -1.1% | - | 2.1% | 1.0% | -1.0% | - |
| Gross profit growth (YoY) | 73.4% | - | -15.0% | -3.7% | -47.1% | - | 25.8% | 15.4% | -3.7% | - |
| Operating income growth (YoY) | 85.7% | - | -16.1% | -2.6% | -51.0% | - | 27.2% | 16.3% | -3.1% | - |
| Net income growth (YoY) | 186.4% | - | -19.2% | 0.9% | -66.6% | - | 37.3% | 21.4% | -0.4% | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | 250.9% | - | - | - | -68.5% | - | - | - | -28.3% | - |
| FCF CAGR (5y) | -6.0% | - | - | - | -21.3% | - | - | - | -1.3% | - |
| Book value growth (YoY) | - | - | - | - | - | - | - | - | - | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2020-12-31.
Product / service
$78.42M totalProduct And Service Other$78.42M · 100.0%
Peer comparison
Same SIC group: Industrial Organic Chemicals
Comparing Westlake Chemical Partners LP against the 5 most active filers in the same SIC group.
Dividends
$1.88/share trailing 12 months · 0.0% YoY
| Ex-date | Per share |
|---|---|
| May 14, 2026 | $0.4710 |
| Feb 6, 2026 | $0.4710 |
| Nov 10, 2025 | $0.4710 |
| Aug 12, 2025 | $0.4710 |
| May 13, 2025 | $0.4710 |
| Feb 7, 2025 | $0.4710 |
| Nov 12, 2024 | $0.4710 |
| Aug 12, 2024 | $0.4710 |
| May 10, 2024 | $0.4710 |
| Feb 1, 2024 | $0.4710 |
| Nov 9, 2023 | $0.4710 |
| Aug 10, 2023 | $0.4710 |
| May 11, 2023 | $0.4710 |
| Feb 1, 2023 | $0.4710 |
| Nov 9, 2022 | $0.4710 |
| Aug 10, 2022 | $0.4710 |
| May 11, 2022 | $0.4710 |
| Feb 2, 2022 | $0.4710 |
| Nov 10, 2021 | $0.4710 |
| Aug 11, 2021 | $0.4710 |
| May 12, 2021 | $0.4710 |
| Feb 3, 2021 | $0.4710 |
| Nov 6, 2020 | $0.4710 |
| Aug 7, 2020 | $0.4710 |